Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / SPONSORED ADR
-
Number of holders
-
886
-
Total 13F shares, excl. options
-
303M
-
Shares change
-
-3.54M
-
Total reported value, excl. options
-
$12.4B
-
Value change
-
-$140M
-
Put/Call ratio
-
0.54
-
Number of buys
-
379
-
Number of sells
-
-380
-
Price
-
$40.88
Significant Holders of GSK plc - SPONSORED ADR (GSK) as of Q3 2024
980 filings reported holding GSK - GSK plc - SPONSORED ADR as of Q3 2024.
GSK plc - SPONSORED ADR (GSK) has 886 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 303M shares
.
Largest 10 shareholders include Dodge & Cox (68.1M shares), FMR LLC (29M shares), JTC Employer Solutions Trustee Ltd (20.5M shares), Fisher Asset Management, LLC (18.6M shares), PRIMECAP MANAGEMENT CO/CA/ (14.9M shares), MORGAN STANLEY (7.95M shares), PRICE T ROWE ASSOCIATES INC /MD/ (7.53M shares), GOLDMAN SACHS GROUP INC (7.37M shares), Royal Bank of Canada (7.17M shares), and STATE STREET CORP (6.78M shares).
This table shows the top 886 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.